Browse wiki

Meeting Agenda  and Meeting Briefing Package/Handouts

Strontium +, Rubidium +, Germanium +, Sodium +, Molybdenum +  and Gallium +

10 CFR 30 +, 10 CFR 35 +, 10 CFR 35.300 +, 10 CFR 35.1000 +, 10 CFR 35.2 +, 10 CFR 35.40 +, 10 CFR 35.51 +, 10 CFR 35.390 +, 10 CFR 35.490 +, 10 CFR 35.491 +, 10 CFR 35.500, Use of Sealed Sources for Diagnosis +, 10 CFR 35.600 +, 10 CFR 35.3047 +, 10 CFR 35.3204 +, 10 CFR 35.3045 +, 10 CFR 35.65 +, 10 CFR 35.50#d +, 10 CFR 35.55#b +, 10 CFR 35.390#1iiG +, 10 CFR 35.3045#a1iii +, 10 CFR 35.3045#a1 +  and 10 CFR 35.491#b2 +

Advisory Committee on Reactor Safeguards +  and Advisory Committee on the Medical Uses of Isotopes +

ML19081A145 +, ML19081A145 +, ML19081A145 +, ML19081A145 +  and ML19081A145 +

1.157407e-5 d (2.777778e-4 hours, 1.653439e-6 weeks, 3.805e-7 months)  +  and 5.555556e-4 d (0.0133 hours, 7.936508e-5 weeks, 1.8264e-5 months)  +

Strontium-90 +, Y-90 +, Radium-223 +, Ra-223 +, Ge-68 +, I-131 +, Iodine-131 +, Yttrium-90 +, Technetium-99 +  and Pd-103 +

Andrea Kock +, Donna-Beth Howe +, Christian Einberg +, Kellee Jamerson +, Lisa Dimmick +, Sophie Holiday +  and Maryann Ayoade +

131I-NaI +, 99mTc-labeled +, 123I-NaI +, 68Ga-labeled +, 111In-leukocy +  and 18F-labeled +

Brachytherapy +, Eye plaque +, TheraSphere +, Overdose +  and Reactive Inspection +